Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Orocidin A/S
A/S
Active
Advertising protection
CVR 44348845
Vandtårnsvej 62A, 2860
Søborg
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2023 · 2 years old
1 employees
www.orocidin.com
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Orocidin A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-0M
-1M
-1M
-1M
-1M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
-1M
2025
Income statement
DKK thousands
Item
2025
Gross profit
-1.351
Staff expenses
-0
EBITDA
-1.351
Depreciation & amort.
-11
EBIT
-1.362
Net financials
-29
Profit before tax
-1.391
Tax
-0
Net profit
-1.391
Balance sheet
DKK thousands
Item
2025
Total assets
9.320
Equity
2.941
Long-term debt
0
Short-term debt
6.379
Total debt
6.379
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-135123200.0%
This company
2025
2025
Equity ratio
31.6%
This company
38.2%
Market median
+17% vs market
2025
2025
Return on equity
-47.3%
This company
18.4%
Market median
-357% vs market
2025
2025
Net profit margin (of gross profit)
-139118300.0%
This company
2025
2025
Asset turnover (of gross profit)
-0.14×
This company
2025
2025
Debt / equity
2.17×
This company
0.62×
Market median
-250% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2023-10-02 – 2025-03-31
View
PDF
More on Orocidin A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
